{"nct_id":"NCT01045590","title":"Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","status_verified_date":"2011-02","start_date":"2003-12","start_date_type":null,"primary_completion_date":"2006-02","primary_completion_date_type":"ACTUAL","completion_date":"2006-02","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}